0000950170-24-094127.txt : 20240808 0000950170-24-094127.hdr.sgml : 20240808 20240808164504 ACCESSION NUMBER: 0000950170-24-094127 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240807 FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HARRISON THOMAS L CENTRAL INDEX KEY: 0001247340 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 241189207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 3 1 ownership.xml 3 X0206 3 2024-08-07 0 0001098972 AGENUS INC AGEN 0001247340 HARRISON THOMAS L 3 FORBES ROAD LEXINGTON MA 02421 true false false false Stock Option 21.00 2023-10-02 2033-10-02 Common Stock 1250 D 1. Stock Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended). The Stock Options were granted prior to the 1 for 20 reverse stock split of the Issuer's common stock in April 2024 and initially represented Stock Options to purchase 25,000 shares of the issuer's common stock with an exercise price of $1.05. Christine M. Klaskin, by Power of Attorney 2024-08-08